IDH2 and central nervous system cancer: Isocitrate dehydrogenase (IDH) genotype has been shown to be a major classifier and prognosticator for gliomas (10, 11) and WHO 2016 classifies astrocytic tumors as to whether they are IDH mutant or IDH wild type.